NEKTAR THERAPEUTICS

NKTR US6402681083

Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).

Annual Performance ¹

2021	2022	2023	2024	2025
-23%	-83%	-74%	58%	15%

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Robin Howard W CEO	47.49 USD	2,156 Sold	102,388 USD	09/09/2025	09/09/2025
Robin Howard W CEO	45.16 USD	2,100 Sold	94,836 USD	09/09/2025	09/09/2025
Robin Howard W CEO	48.18 USD	1,210 Sold	58,298 USD	09/09/2025	09/09/2025
Robin Howard W CEO	46.41 USD	1,200 Sold	55,692 USD	09/09/2025	09/09/2025
Robin Howard W CEO	37.87 USD	3,304 Sold	125,122 USD	04/09/2025	05/09/2025
Robin Howard W CEO	39.89 USD	1,136 Sold	45,315 USD	04/09/2025	05/09/2025
Robin Howard W CEO	38.82 USD	2,226 Sold	86,413 USD	04/09/2025	05/09/2025
Zalevsky Jonathan SR OFF	34.41 USD	189 Sold	6,503 USD	04/09/2025	04/09/2025
Robin Howard W CEO	34.40 USD	613 Sold	21,087 USD	04/09/2025	04/09/2025
Zalevsky Jonathan SR OFF	32.43 USD	793 Sold	25,717 USD	04/09/2025	04/09/2025

Load More

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include NEKTAR THERAPEUTICS to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Historical Performance

1M	3M	6M	1Y	3Y	5Y	All Time
-21%	-20%	29%	100%	-95%	-95%	-93%

Last	52W Low	52W High	All-Time Low	All-Time High	β
59.93	0.49	60.55	0.49	60.55

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Robin Howard W	23	1,103,987.09	47,999.44	17/11/2023	09/09/2025
Zalevsky Jonathan	15	204,752.58	13,650.17	17/11/2023	04/09/2025
Wilson Mark Andrew	11	120,669.22	10,969.93	17/11/2023	19/08/2025
Chess Robert	1	23,400.00	23,400.00	14/06/2024	14/06/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
Twist Bioscience Corporation	US90184D1000	TWST

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.